UnknownNot Applicable

ECMELLA vs. ECMO on 30-day Mortality

Germany60 participantsStarted 2022-02

Plain-language summary

This international, multicenter cohort study aims to investigate outcomes after treatment with extracorporeal cardiopulmonary resuscitation (eCPR) during cardiac arrest.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients * Cardiac arrest * Treatment with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) or "ECMELLA" (that is VA-ECMO plus left ventricular Impella® micro-axial pump) Exclusion Criteria: * Non-adult patients * No treatment with VA-ECMO or "ECMELLA"

What they're measuring

30-day mortality

Timeframe: Mortality within 30 days after cardiac arrest event.

Trial details

NCT IDNCT05175898

SponsorCharite University, Berlin, Germany

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-10

View on ClinicalTrials.gov More Cardiac Arrest trials